[The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
D062365:Aminobenzoates / Q000494:pharmacology*; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006490:Hemostatics / Q000494:pharmacology*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000502:physiology*; D007275:Injections, Intravenous; D010949:Plasma; D011516:Prothrombin / Q000032:analysis; D012911:Snakes; D013917:Thrombin / Q000032:analysis; D013925:Thromboplastin / Q000032:analysis; D014688:Venoms / Q000494:pharmacology*; D014812:Vitamin K / Q000627:therapeutic use; D006475:Vitamin K Deficiency Bleeding / Q000517:prevention & control
D062365:Aminobenzoates; D006490:Hemostatics; D014688:Venoms; D014812:Vitamin K; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen; D013925:Thromboplastin; D013917:Thrombin
Die Wirkung von Plasmafraktion I-O, ACC 76, PAMBA und Haemarctin auf das Gerinnungssystem der unreifen Neugeborenen.